{"id":"https://openalex.org/W2122001979","doi":"https://doi.org/10.1067/mcp.2002.127944","title":"Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers","display_name":"Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers","publication_year":2002,"publication_date":"2002-10-01","ids":{"openalex":"https://openalex.org/W2122001979","doi":"https://doi.org/10.1067/mcp.2002.127944","mag":"2122001979","pmid":"https://pubmed.ncbi.nlm.nih.gov/12386639"},"language":"en","primary_location":{"id":"doi:10.1067/mcp.2002.127944","doi":"https://doi.org/10.1067/mcp.2002.127944","is_oa":false,"landing_page_url":"https://doi.org/10.1067/mcp.2002.127944","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051271682","display_name":"Brent M. Booker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brent M. Booker","raw_affiliation_strings":["Department of Pharmaceutical Sciences, State University of New York, Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, State University of New York, Buffalo","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074375293","display_name":"Mindy He Magee","orcid":"https://orcid.org/0009-0009-6267-3319","observed_orcids":["https://orcid.org/0009-0009-6267-3319"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mindy He Magee","raw_affiliation_strings":["Department of Pharmaceutical Sciences, State University of New York, Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, State University of New York, Buffalo","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111914294","display_name":"Robert A. Blum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Blum","raw_affiliation_strings":["Department of Pharmaceutical Sciences, State University of New York, Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, State University of New York, Buffalo","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059748302","display_name":"Christian D. Lates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian D. Lates","raw_affiliation_strings":["Department of Pharmaceutical Sciences, State University of New York, Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, State University of New York, Buffalo","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021901997","display_name":"William J. Jusko","orcid":"https://orcid.org/0000-0003-4027-0550","observed_orcids":["https://orcid.org/0000-0003-4027-0550"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William J. Jusko","raw_affiliation_strings":["Department of Pharmaceutical Sciences, State University of New York, Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, State University of New York, Buffalo","institution_ids":["https://openalex.org/I63190737"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021901997"],"corresponding_institution_ids":["https://openalex.org/I63190737"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":1.0627,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.74539877,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"72","issue":"4","first_page":"370","last_page":"382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7407000064849854,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7407000064849854,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.17649999260902405,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.01489999983459711,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":0.9490000009536743},{"id":"https://openalex.org/keywords/methylprednisolone","display_name":"methylprednisolone","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8740000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.7829999923706055},{"id":"https://openalex.org/keywords/t-helper-cells","display_name":"T helper cells","score":0.8529999852180481},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9929999709129333},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7710000276565552},{"id":"https://openalex.org/keywords/controlled-release-formulation","display_name":"controlled-release formulation","score":0.42399999499320984},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7749999761581421},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.40299999713897705},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7599999904632568},{"id":"https://openalex.org/keywords/50-inhibitory-concentration","display_name":"50% inhibitory concentration","score":0.7369999885559082},{"id":"https://openalex.org/keywords/glucocorticoid-receptor","display_name":"glucocorticoid receptor","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2776741139","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem","level":3,"score":0.9303067922592163},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.9051527976989746},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7775200605392456},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7436054944992065},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5811647176742554},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5101988315582275},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46706873178482056},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.42430320382118225},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.379226416349411},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31221622228622437},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008775","descriptor_name":"Methylprednisolone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008775","descriptor_name":"Methylprednisolone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018709","descriptor_name":"Statistics, Nonparametric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1067/mcp.2002.127944","doi":"https://doi.org/10.1067/mcp.2002.127944","is_oa":false,"landing_page_url":"https://doi.org/10.1067/mcp.2002.127944","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:12386639","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12386639","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G7456126135","display_name":null,"funder_award_id":"24211","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"}],"funders":[{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2052900868","https://openalex.org/W2080154421","https://openalex.org/W4246587260","https://openalex.org/W2074999857","https://openalex.org/W2021667108","https://openalex.org/W2049465301","https://openalex.org/W2082224281","https://openalex.org/W2021824652","https://openalex.org/W2022028441","https://openalex.org/W2002296115"],"abstract_inverted_index":{"OBJECTIVES:":[0],"The":[1,99,144,166],"pharmacokinetics":[2],"and":[3,12,59,71,86,88,126,187,210,239,241,265],"pharmacodynamics":[4],"after":[5],"administration":[6],"of":[7,41,64,93,101,109,146,153,228,287],"methylprednisolone":[8,102,163,220,237,261,267],"alone,":[9,11,52,221],"diltiazem":[10,51,72,110,147,271],"both":[13,65],"drugs":[14,66],"jointly":[15],"were":[16,81,160,171,272],"assessed":[17,75,82],"in":[18,31,106,117,150,268,279,284],"healthy":[19,33],"volunteers.":[20],"METHODS:":[21],"An":[22],"unblinded,":[23],"controlled,":[24],"fixed-sequence,":[25],"2-period":[26],"study":[27],"was":[28,74,103,148,213,223],"carried":[29],"out":[30],"5":[32],"white":[34],"men":[35],"who":[36],"received":[37],"a":[38,118],"single":[39],"dose":[40],"intravenous":[42],"methylprednisolone,":[43],"0.3":[44],"mg/kg,":[45],"on":[46,55,67],"day":[47,68],"2,":[48],"followed":[49],"by":[50,83,91,203],"180":[53,233],"mg,":[54,234],"days":[56],"5,":[57],"6,":[58],"7,":[60],"with":[61,270],"joint":[62],"dosing":[63],"8.":[69],"Methylprednisolone":[70],"disposition":[73],"from":[76],"plasma":[77,84,131],"concentrations.":[78],"Pharmacodynamic":[79],"factors":[80],"cortisol":[85,280],"T-helper":[87,185],"T-suppressor":[89,194],"lymphocytes":[90],"means":[92],"extended":[94],"indirect":[95],"response":[96],"models.":[97],"RESULTS:":[98],"clearance":[100],"significantly":[104,235],"reduced":[105,226,242],"the":[107,130,151,204,207,216,250,285],"presence":[108,152,286],"(25.2":[111],"L/h":[112],"versus":[113,123,139,164,174,181,190,219],"16.8":[114],"L/h),":[115],"resulting":[116],"longer":[119],"half-life":[120,240],"(2.28":[121],"hours":[122],"3.12":[124],"hours)":[125],"increased":[127,236],"area":[128,205],"under":[129],"concentration-time":[132],"curve":[133,209],"(AUC)":[134],"(871":[135],"ng":[136,141],"x":[137,142],"h/mL":[138],"1299":[140],"h/mL).":[143],"AUC":[145,238],"unchanged":[149],"methylprednisolone.":[154,229],"No":[155],"significant":[156,253],"intrinsic":[157],"pharmacodynamic":[158],"differences":[159,254],"observed":[161,214],"for":[162,177,184,193,215,260,266],"methylprednisolone-diltiazem.":[165],"50%":[167,256],"inhibitory":[168,257],"concentration":[169,258],"values":[170,259],"0.446":[172],"ng/mL":[173,176,180,183,189,192],"0.780":[175],"cortisol,":[178],"9.20":[179],"10.7":[182],"cells,":[186],"18.5":[188],"20.9":[191],"cells":[195],"(P":[196],">.05).":[197],"Greater":[198],"net":[199],"suppression,":[200],"as":[201],"indicated":[202],"between":[206,255],"effect":[208],"suppression":[211],"ratios,":[212],"methylprednisolone-diltiazem":[217],"combination":[218,269],"which":[222,275],"attributed":[224],"to":[225,245,249],"elimination":[227],"CONCLUSIONS:":[230],"Controlled-delivery":[231],"diltiazem,":[232],"clearance,":[243],"lending":[244],"greater":[246],"systemic":[247],"exposure":[248],"steroid.":[251],"However,":[252],"when":[262],"given":[263],"alone":[264],"not":[273],"seen,":[274],"implies":[276],"no":[277],"change":[278],"or":[281],"cell-trafficking":[282],"sensitivity":[283],"diltiazem.":[288]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}